- Savage Medical Exits Stealth With Over $3 Million to Enable Minimally Invasive Colorectal Tumor Removal
- Inspira Technologies Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients
- Function of Research Liquids in Biomedical Researches
- Asep Medical Holdings Inc. is Granted Patent Approval for its AI-based Sepsis Diagnostic Technology in the US
- Alto Neuroscience Closes $45 Million in Oversubscribed Series C Financing
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.
Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.
Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.
"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"
National study: Health Systems Lose $3.1 Billion In Physical Therapy Revenue
“Referral leakage is deeply worrying for health systems, and investing in costly additional locations is not the answer. Health systems need to find creative, innovative solutions to survive, post-pandemic. Offering outpatient physical therapy direct to a patient’s home is a truly advantageous strategy. It expands patient access and geographic coverage, enhances patient satisfaction, and standardizes patient care,” said Palak Shah, co-founder and head of clinical services at Luna.
Konica Minolta’s Microsoft Azure-hosted Platform Automates Exchange of Healthcare Data
Konica Minolta Connected Care, a cloud-based workflow automation platform designed to streamline manual processes such as patient intake, care transitions and referral management across acute, post-acute and ambulatory care settings. The solution automatically converts unstructured data to structured, automates manual tasks in daily workflows, generates EHR records and reduces administrative burdens for healthcare organizations to improve revenue and expedite care. Konica Minolta Connected Care is hosted in Microsoft Azure and is available through the Microsoft Azure Marketplace.
Medical Syringe: The Alternatives With High-Quality Materials
Medical syringes are indispensable tools in healthcare settings, facilitating the safe and precise administration of medications, vaccines, and other substances. Traditionally made from glass or
Medovate Signs First Distributor Agreement for its Pioneering SAFIRA® Technology in the Veterinary Field with 20/20 Imaging in the USA
Bob Salzman, President 20/20 Imaging said: “This is a ground-breaking new technology for safer regional anesthesia and is unique in making it a one person procedure and reducing reliance on subjective ‘injection pressure feel’. 20/20 Imaging are proud to be the first appointed distributor to be bringing its unique benefits to the veterinary market and we look forward to making this exciting technology available to veterinary professionals across America alongside our leading range of ultrasound solutions to enable them to deliver the best care for their patients.”
Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future
Synergy Health Network’s $100 Mil Expansion Starts with Crowdfunding via Rialto Markets
Synergy Health Network is giving investors the chance to back its expansion plans after teaming up with Rialto Markets to utilise the award-winning broker-dealer’s crowdfunding platform and infrastructure for a $1 million Reg CF raise to launch Synergy’s four-year growth mission.
Deciphex Raises $11.5M in Series B Funding Led by ACT Venture Capital
Deciphex will leverage the funding to continue driving global growth and to consolidate its position as a leader in revolutionising clinical and non-clinical pathology
Industry Expert Byline
The Rise of AI-Integrated Medical Devices: What’s Changing in 2025 and Beyond
Almost every healthcare system today relies on well-established specialties – cardiology, radiology, endocrinology, and more, to deliver care within clearly defined domains. These expert-driven disciplines, supported by tried-and-true processes and technologies, have long formed the backbone of modern medicine. Clinicians are trained and evaluated based on their deep knowledge and mastery within these areas. And for the most part, this approach works.
Revvity Expands Access to Base Editing Technology with Aim to Accelerate Discovery to Cure
Michelle Fraser, head of cell and gene therapy at Revvity, underscores the importance of providing broad access to this technology: “Base editing has been extensively demonstrated in numerous studies to safely and precisely control the correction of single base changes at multiple target sites, simultaneously. This streamlined approach simplifies complex multi-gene editing, holding great promise for the development of new cell therapies targeting rare inherited genetic diseases, cancer, and in the creation of universal donor cells as the foundation of allogeneic cell therapies.”
PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial
The EV-302 study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS), compared to chemotherapy. An Independent Data Monitoring Committee determined that OS crossed the pre-specified efficacy boundary at interim analysis. The safety results of the combination are consistent with those of enfortumab vedotin in combination with pembrolizumab previously reported in cisplatin-ineligible patients with la/mUC.
Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies
EarlySense Sells IP To Hillrom for $30M+ – Focuses on Virtual/Home Patient Monitoring
“We set out to save lives and improve care by implementing AI-based contact-free patient monitoring in healthcare facilities across the globe,” said Matt Johnson, CEO of EarlySense.
Olympus Corporation to Acquire Quest Photonic Devices B.V.
Olympus Corporation announced that it has entered into an agreement to acquire Quest Photonic Devices B.V. for up to EUR50 million including milestone payments to strengthen its surgical endoscopy capabilities.
FDA Medical Device Updates
Our Experts - Byline Articles
Medical Imaging Technologies and Their Impact on Modern Healthcare
Healing Headlines, Transforming Lives: Hospitals in the News
Philips and Gibraltar Health Authority Announce 16-year Strategic Partnership
For the first time, patients will no longer need to travel abroad for treatment of acute cardiac diseases, as the Gibraltar Health Authority prepares to provide local coronary angiography and angioplasty services in a new interventional cardiac suite.
